Cardlytics, Inc.
CDLXCommunication ServicesNASDAQAdvertising Agencies
Scan Results
Daily timeframeHeadquartered within the communication services sector, Cardlytics, Inc. focuses on Advertising Agencies services and products. Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company carries a $23.0M market cap, placing it firmly in the micro-cap category. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Market Cap
$23.0M
Beta
0.62
P/E (TTM)
—
P/E (Fwd)
-1.12
EPS (TTM)
$-20.36
EPS (Fwd)
$-3.55
ROE
-356.0%
ROA
-7.7%
Cash
$59.8M
Total Debt
$210.0M
Free CF
$15.8M
52W Change
-86.1%
Annual Financials
Cash vs Debt
Where CDLX stands vs its 150-day and 200-day moving averages
As of the July 15, 2026 close, CDLX finished 51.16% below its 150-day moving average ($8.64) and 61.43% below its 200-day moving average ($10.94). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CDLX overbought or oversold?
At the July 15, 2026 close, CDLX's RSI(14) was 25.2, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $59.8M in cash, though total debt stands at $210.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $15.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -356.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been uneven over recent years, ranging from $267.1M to $233.3M.
With a beta below 0.7, Cardlytics, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CDLX.